MARTIN ANDREANSKY to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications MARTIN ANDREANSKY has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
0.666
-
Intra-Arterial Platelet Infusion for Intractable Hemorrhage and Refractory Thrombocytopenia in Children With Gastrointestinal Graft-Versus-Host Disease. Pediatr Blood Cancer. 2015 Dec; 62(12):2226-8.
Score: 0.275
-
Long-term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial. Am J Hematol. 2024 04; 99(4):785-788.
Score: 0.125
-
Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric Patients. Biol Blood Marrow Transplant. 2019 03; 25(3):556-561.
Score: 0.086
-
Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial. Biol Blood Marrow Transplant. 2018 06; 24(6):1216-1222.
Score: 0.082
-
Outcomes after hematopoietic stem cell transplantation for children with I-cell disease. Biol Blood Marrow Transplant. 2014 Nov; 20(11):1847-51.
Score: 0.064
-
Granulocyte Colony-Stimulating Factor Is Safe and Well Tolerated following Allogeneic Transplantation in Patients with Sickle Cell Disease. Transplant Cell Ther. 2022 03; 28(3):174.e1-174.e5.
Score: 0.027
-
Successful treatment of disseminated fusariosis. Bone Marrow Transplant. 2003 Mar; 31(5):411-2.
Score: 0.007